electroCore, Inc. Proceeds from Sale and Maturity of Marketable Securities
electroCore, Inc. (ECOR) reported Proceeds from Sale and Maturity of Marketable Securities of $4.54 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2025-05-07
- electroCore, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2025-03-31 was $4.54M.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-12-31 was $1.00M, a 83.33% decline year-over-year.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-09-30 was $8.00M.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-06-30 was $7.30M.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for fiscal 2021 was $23.30M, a 41.21% increase from fiscal 2020.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for fiscal 2020 was $16.50M, a 81.31% decline from fiscal 2019.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for fiscal 2019 was $88.27M, a 98.31% increase from fiscal 2018.
- electroCore, Inc. proceeds from sale and maturity of marketable securities for fiscal 2018 was $44.51M, a 426.12% increase from fiscal 2017.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-03-31 | $4.54M 10-Q · filed 2025-05-07 | |||
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $9.00M derived: sum of 2 quarters · filed 2023-03-08 | $16.30M derived: sum of 3 quarters · filed 2023-03-08 | $23.30M 10-K · filed 2023-03-08 |
| 2021-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.30M derived: sum of 2 quarters · filed 2022-11-03 | $22.30M 10-Q · filed 2022-11-03 | $28.30M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $14.30M 10-Q · filed 2022-08-04 | $20.30M derived: sum of 3 quarters · filed 2022-08-04 | $20.30M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $7.00M 10-Q · filed 2022-05-05 | $13.00M derived: sum of 2 quarters · filed 2022-05-05 | $13.00M derived: sum of 3 quarters · filed 2022-05-05 | $13.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $6.00M derived: sum of 2 quarters · filed 2022-03-10 | $6.00M derived: sum of 3 quarters · filed 2022-03-10 | $16.50M 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $10.50M 10-Q · filed 2021-11-04 | $29.00M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $10.50M 10-Q · filed 2021-08-05 | $29.00M derived: sum of 3 quarters · filed 2021-08-05 | $49.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $10.50M 10-Q · filed 2021-05-06 | $29.00M derived: sum of 2 quarters · filed 2021-05-06 | $49.50M derived: sum of 3 quarters · filed 2021-05-06 | $70.86M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $39.00M derived: sum of 2 quarters · filed 2021-03-11 | $60.37M derived: sum of 3 quarters · filed 2021-03-11 | $88.27M 10-K · filed 2021-03-11 |
| 2019-09-30 | $20.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $41.87M derived: sum of 2 quarters · filed 2020-11-12 | $69.77M 10-Q · filed 2020-11-12 | $87.77M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $21.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $49.27M 10-Q · filed 2020-08-13 | $67.27M derived: sum of 3 quarters · filed 2020-08-13 | $66.86M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $27.90M 10-Q · filed 2020-05-15 | $45.90M derived: sum of 2 quarters · filed 2020-05-15 | $45.49M derived: sum of 3 quarters · filed 2020-05-15 | $63.22M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $17.59M derived: sum of 2 quarters · filed 2020-03-30 | $35.32M derived: sum of 3 quarters · filed 2020-03-30 | $44.51M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$406.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $17.32M derived: sum of 2 quarters · filed 2019-11-14 | $26.51M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $17.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $26.92M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $9.19M 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $8.46M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |